Advances in Traditional Medicine

Kyung Hee Oriental Medicine Research Center (경희대학교 융합한의과학연구소)
권호 표지
DOI QR코드

DOI QR Code

A single blind randomised placebo controlled clinical trial of a classical Ayurvedic formulation Ashokarista in the treatment of menorrhagia and dysmenorrhoea

  • Published : 2007.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

A well known Ayurvedic formulation Ashokarista, used for menstrual disorders has been studied in a single blind randomised placebo controlled clinical trial for the treatment of menorrhagia and dysmenorrhoea. Dysmenorrhoea and menorrhagia patients who were taking Ashokarista (20 ml twice daily) for 10 menstrual cycles had an increase in haemoglobin level. Menorrhagia treated group has shown to reduce the erythrocyte sedimentation rate level that has been increased in the menorrhagia control group. The platelet count, total count and differential count were observed unchanged in the study. The Ashokarista did not affect the SGPT and SGOT level, which signify its lack of toxicity in hepatic function. The treated menorrhagic patients showed an increase in serum albumin content and decrease in blood clotting time, whereas the serum protein content was observed unchanged. There was a significant increase in both serum cholesterol and triglyceride level, which usually associated with the use of oral contraceptives. No major side effects were observed by the clinicians during the study.

Keywords

References

  1. Akthar Y, Jabbar S, Hannan JMA, Alamgir M, Choudhuri MSK, Khan MTH. (2001) Neuropharmacological study of Asokarista- an ayurvedic formulation. Orient. Pharm. Exp. Med. 1, 18-26
  2. Anonymous. (1992) Bangladesh National Formulary of Ayurvedic Medicine. p. 20, National Unani and Ayurvedic Formulary Committee Bangladesh, Board of Unani and Ayurvedic System of Medicine, Bangabandhu Avenue, Dhaka
  3. Baker ME. (1995) Endocrine activity of plant derived compounds: an evolutionary perspective. Proc. Soc. Exp. Biol. Med. 208, 131-138
  4. Bowman WC, Rand MJ. (1980) Textbook of Pharmacology 2nd ed., pp. 20-22, Blackwell Scientific Publications, New York
  5. Clavey SW. (2004) Compositions and methods for treating gynaecological disorders. PCT Int. Appl. WO 2003-AU820 20030627
  6. Jones AE. (2004) Managing the pain of primary and secondary dysmenorrhoea. Nurs Times 100, 40-43
  7. Kiuchi F, Shibuya M, Kinoshita T, Sankawa U. (1983) Inhibition of prostaglandin biosynthesis by the constituents of medicinal plants. Chem. Pharm. Bull. 31, 3391-3396
  8. Kiuchi F, Iwakami S, Shibuya M, Hanaoka F, Sankawa U. (1992) Inhibition of prostaglandin and leukotriene biosynthesis by gingerols and diarylheptanoids. Chem. Pharm. Bull. 40, 387-391
  9. Lewis WH, Elvin-Lewis MPF. (2003) Medical Botany: Plants affecting human health. 2nd ed., pp. 521-531, John Wiley & Sons, Hoboken, New Jersey
  10. Middekoop TB, Labadie RP. (1985) The action of Saraca asoca (Roxb.) De Wilde bark on the PGH2 synthetase enzyme complex of the sheep vesicular gland. Z. Naturforsch. C. J. Biosci. 40, 523-526
  11. Narimanian M, Badalyan M, Panosyan V, Gabrielyan E, Panossian A, Wickman G, Wagner H. (2005). Randomized trial of a fixed combination ($KanJang^{\circledR}$) ofherbal extracts containing Adhatoda vasica, Echinacea purpurea and Eleutherococcus senticocus in patients with upper respiratory tract infections. Phytomedicine 12, 539-547 https://doi.org/10.1016/j.phymed.2004.10.001
  12. Oehler MK, Rees MCP. (2003) Menorrhagia: an update. Acta Obstet. Gynecol. Scand. 82, 405-422 https://doi.org/10.1034/j.1600-0412.2003.00097.x
  13. Sonnenwirth AC, Jarett L. (1982) Gradwohl's Clinical Laboratory Methods and Diagnosis. 8th ed., p. 506, CV Mosby Co., Missouri
  14. Taha RAM. (2004) Spasmolytic and calcium antagonist activities of thymoquinone. Egypt. J. Biomed. Sci. 16, 152-167
  15. Tapanainen JS. (2004) Medical management of menstrual disorders. International Congress Series, Adv. Fertility Reprod. Med. 1266, 63-68 https://doi.org/10.1016/j.ics.2004.01.106
  16. Venkateshwarlu V. (1997). Cyclo-oxygenase inhibitors from spices. Indian Drugs 34, 427-432
  17. Wagner H. (2004) Natural products chemistry and phytomedicine in the twenty-first century: new developments and challenges. pp. 26-31, Plenary Lecture, Second International Conference on Biodiversity, New Delhi
  18. Wen D, Zhang R, Chen S. (2003) Separation of chemical components in Cyperus rotundus rhizomes and its effects on ovary muscular contraction of uncyophoric rats in vitro. Beijing Da Xue Xue Bao 35, 110-111
  19. Williamson E. (2001) Synergy and other interactions in phytomedicines. Phytomedicine 8, 401-409 https://doi.org/10.1078/0944-7113-00060
  20. Wilson ML, Murphy PA. (2001) Herbal and dietary therapies for primary and secondary dysmenorrhoea. Cochrane Database Syst. Rev. 3, CD002124 https://doi.org/10.1002/14651858.CD002124
  21. Wynn B. (1979) Comparison of effects of different oral contraceptive formulations on carbohydrate and lipid metabolism. Lancet 1, 1045-1049 https://doi.org/10.1016/S0140-6736(79)92949-0
  22. Ylikorkala O. (1978) New concepts in dysmenorrhoea. Am. J. Obstet. Gynecol. 130, 833